Literature DB >> 11123722

The evolution of Alzheimer's disease-related cytoskeletal pathology in the human raphe nuclei.

U Rüb1, K Del Tredici, C Schultz, D R Thal, E Braak, H Braak.   

Abstract

The cross-sectional analyses currently available show that the Alzheimer's disease (AD)-related cytoskeletal alterations within the human brain affect variously susceptible areas of the cerebral cortex in a uniform sequence with very little interpatient variability. This sequence has been divided for research and comparative purposes into six stages (cortical NFT/NT-stages I-VI). Among the subcortical nuclei affected in AD are those belonging to the raphe system. Efforts were focused on the lesions present in these nuclei to see in which of the six stages the AD-related cytoskeletal anomalies begin and whether a correlation exists between the AD-related pathology developing within the cerebral cortex and the cytoskeletal damage that occurs in the nuclei of the raphe system. To this end, serial sections from the brainstems of 27 post-mortem cases with stages I-VI of cortical cytoskeletal lesions were examined. The cytoskeletal pathology was visualized using the modified silver iodide-Gallyas staining technique and the antibody AT8. The latter is directed specifically against the abnormally phosphorylated cytoskeletal protein tau. The dorsal raphe nucleus manifests the cytoskeletal lesions early on (stages I-II). The central and linear raphe nuclei, by contrast, do so initially in stages III-IV, and the caudal raphe nuclei register the first changes in stages V-VI. In stages V and VI, the dorsal raphe nucleus displays the most severe cytoskeletal pathology within the raphe system, followed by the central and linear raphe nuclei, whereas the cytoskeletal anomalies in the caudal raphe nuclei are slight. The developing damage within the nuclei of the raphe system correlates with the stages I-VI and, furthermore, progresses in the oral raphe nuclei in close connection with the evolution of the pathological process in cortical projection destinations of these nuclei. As the source of the ascending serotonergic system, the involvement of the oral raphe nuclei may be partially responsible for the early manifestation of the non-cognitive and emotional deficiencies possibly traceable to dysfunctions within the ascending serotonergic system.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11123722     DOI: 10.1046/j.0305-1846.2000.00291.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  37 in total

Review 1.  Mild cognitive impairment: pathology and mechanisms.

Authors:  Elliott J Mufson; Lester Binder; Scott E Counts; Steven T DeKosky; Leyla de Toledo-Morrell; Stephen D Ginsberg; Milos D Ikonomovic; Sylvia E Perez; Stephen W Scheff
Journal:  Acta Neuropathol       Date:  2011-11-19       Impact factor: 17.088

Review 2.  Turning on the Light Within: Subcortical Nuclei of the Isodentritic Core and their Role in Alzheimer's Disease Pathogenesis.

Authors:  Panos Theofilas; Sara Dunlop; Helmut Heinsen; Lea Tenenholz Grinberg
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

3.  A method for inferring regional origins of neurodegeneration.

Authors:  Justin Torok; Pedro D Maia; Fon Powell; Sneha Pandya; Ashish Raj
Journal:  Brain       Date:  2018-03-01       Impact factor: 13.501

4.  Neuropathologic basis of in vivo cortical atrophy in the aphasic variant of Alzheimer's disease.

Authors:  Daniel T Ohm; Angela J Fought; Alfred Rademaker; Garam Kim; Jaiashre Sridhar; Christina Coventry; Tamar Gefen; Sandra Weintraub; Eileen Bigio; Marek Marsel Mesulam; Emily Rogalski; Changiz Geula
Journal:  Brain Pathol       Date:  2019-09-12       Impact factor: 6.508

5.  Disease specificity and pathologic progression of tau pathology in brainstem nuclei of Alzheimer's disease and progressive supranuclear palsy.

Authors:  Brittany N Dugger; Michael Tu; Melissa E Murray; Dennis W Dickson
Journal:  Neurosci Lett       Date:  2011-01-12       Impact factor: 3.046

Review 6.  Can Animal Models Inform on the Relationship between Depression and Alzheimer Disease?

Authors:  Jennifer N K Nyarko; Maa O Quartey; Glen B Baker; Darrell D Mousseau
Journal:  Can J Psychiatry       Date:  2018-04-23       Impact factor: 4.356

7.  Alzheimer disease-related presenilin-1 variants exert distinct effects on monoamine oxidase-A activity in vitro.

Authors:  Paul R Pennington; Zelan Wei; Lewei Rui; Jennifer A Doig; Brett Graham; Kelly Kuski; Geraldine G Gabriel; Darrell D Mousseau
Journal:  J Neural Transm (Vienna)       Date:  2011-03-04       Impact factor: 3.575

8.  Molecular imaging of serotonin degeneration in mild cognitive impairment.

Authors:  Gwenn S Smith; Frederick S Barrett; Jin Hui Joo; Najlla Nassery; Alena Savonenko; Devin J Sodums; Christopher M Marano; Cynthia A Munro; Jason Brandt; Michael A Kraut; Yun Zhou; Dean F Wong; Clifford I Workman
Journal:  Neurobiol Dis       Date:  2017-05-13       Impact factor: 5.996

9.  The distribution of phosphorylated tau in spinal cords of Alzheimer's disease and non-demented individuals.

Authors:  Brittany N Dugger; Jose A Hidalgo; Glenn Chiarolanza; Monica Mariner; Jonette Henry-Watson; Lucia I Sue; Thomas G Beach
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

Review 10.  Neuropathology and cognitive impairment in Alzheimer disease: a complex but coherent relationship.

Authors:  Peter T Nelson; Heiko Braak; William R Markesbery
Journal:  J Neuropathol Exp Neurol       Date:  2009-01       Impact factor: 3.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.